Evidence map›Paper›PMID 24096136›Full record

ArticleNeuroscience2013

Gephyrin plays a key role in BDNF-dependent regulation of amygdala surface GABAARs.

L Mou, B G Dias, H Gosnell, K J Ressler

Abstract read
In one paragraph

Article in Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. BDNF controls GABANeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

L MouDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
B G Dias
H Gosnell
K J Ressler

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI WALLEN, KIM · 1985 to 2011
$114.0M
Genetic and estrogen-dependent regulation of the human PAC1R receptor and PTSDR01MH096764 · NIMH · MCLEAN HOSPITAL · PI RESSLER, KERRY J. · 2012 to 2016
$2.1M
Molecular Regulation of GABA(A) Receptor Function in AmygdalaR01DA019624 · NIDA · EMORY UNIVERSITY · PI RESSLER, KERRY J. · 2006 to 2010
$1.8M
NCRR NIH HHS P51 RR000165NCRR NIH HHS P51RR000165NIDA NIH HHS DA019624NIDA NIH HHS R01 DA019624NIMH NIH HHS MH096764NIMH NIH HHS R01 MH096764
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) is critically involved in synaptic plasticity and neurotransmission. Our lab has previously found that BDNF activation of neurotrophic tyrosine kinase, receptor, type 2 (TrkB) is required for fear memory formation and that GABAA receptor (GABAAR) subunits and the GABAA clustering protein gephyrin are dynamically regulated during fear memory consolidation. We hypothesize that TrkB-dependent internalization of GABAARs may partially underlie a transient period of amygdala hyperactivation during fear memory consolidation. We have previously reported that BDNF modulates GABAAR α1 subunit sequestration in cultured hippocampal and amygdala neurons by differential phosphorylation pathways. At present, no studies have investigated the regulation of gephyrin and GABAAR α1 subunits following BDNF activation in the amygdala. In this study, we confirm the association of GABAAR α1 and γ2 subunits with gephyrin on mouse amygdala neurons by coimmunoprecipitation and immunocytochemistry. We then demonstrate that rapid BDNF treatment, as well as suppression of gephyrin protein levels on amygdala neurons, induced sequestration of surface α1 subunits. Further, we find that rapid exposure of BDNF to primary amygdala cultures produced decreases in gephyrin levels, whereas longer exposure resulted in an eventual increase. While total α1 subunit levels remained unchanged, gephyrin was downregulated in whole cell homogenates, but enhanced in complexes with GABAARs. Our data with anisomycin suggest that BDNF may rapidly induce gephyrin protein degradation, with subsequent gephyrin synthesis occurring. Together, these findings suggest that gephyrin may be a key factor in BDNF-dependent GABAAR regulation in the amygdala. This work may inform future studies aimed at elucidating the pathways connecting BDNF, GABAA systems, gephyrin, and their role in underlying amygdala-dependent learning.

Indexed as

AmygdalaAnimalsBlotting, WesternBrain-Derived Neurotrophic FactorCarrier ProteinsGene Expression RegulationHumansImmunohistochemistryImmunoprecipitationMembrane ProteinsMiceMice, Inbred C57BLNeuronsReceptors, GABA-ATransfectionBrain-Derived Neurotrophic FactorCarrier ProteinsgephyrinMembrane ProteinsReceptors, GABA-AamygdalaBDNFbrain-derived neurotrophic factorconsolidationfearGABAGABA(A) receptorsGABA(A)RsgephyrinGFPgreen fluorescent proteinICCimmunocytochemistryimmunoprecipitationIPmemoryneurotrophic tyrosine kinase, receptor, type 2PBSphosphate-buffered salineSDS–PAGEsodium dodecyl sulfate polyacrylamide gel electrophoresisTrkB

Identifiers

PMID24096136
PMCPMC3910431

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.